The global ophthalmic surgical instruments market size was estimated to be USD 11.90 billion in 2023 and is expected to reach at USD 23.75 billion by 2034 with a CAGR of 6.48% during the forecast period 2024-2034. Rising prevalence of ophthalmic disorders such as glaucoma, cataract, & diabetic retinopathy, surge in geriatric population, growing government initiatives & support for the visually impaired population, and increasing technological advancements in ophthalmology surgery devices are some of the key factors boosting the market growth.
Increasing technological advancements in ophthalmology surgery devices is predicted to boost the market growth during the forecast period. Ophthalmic surgical tools are essential for patients' complete comfort and convenience. The tools enable the eye expert to precisely determine each patient's condition and suggest the best course of treatment for recovery. The successful and effective use of this technology improves the overall eye screening procedure. For instance, in April 2022, Alcon has unveiled the Alcon Fidelis Virtual Reality (VR) Ophthalmic Surgical Simulator, a portable virtual reality device designed for trainee cataract surgeons. This simulator provides a realistic virtual operating room experience, complete with haptic feedback to replicate the visual and tactile aspects of cataract surgery.
By product, cataract surgery devices was the highest revenue-grossing segment in the global ophthalmic surgical instruments market in 2023 owing to the surge in number of cataract cases that require surgery, growing launch of new products, rising technological advancements in cataract surgery devices, increasing product launches in ophthalmology surgery devices. For instance, in August 2022, Sight Sciences, Inc., a company specializing in eye care technology with a mission to create innovative solutions that revolutionize healthcare and enhance patient well-being, has introduced SION, a surgical device that marks a significant advancement in the field of goniotomy innovation and practice. Additionally, Glaucoma surgery devices is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of glaucoma, increasing technological advancements, and growing launch of advanced products.
By end-user, hospitals was the highest revenue-grossing segment in the global ophthalmic surgical instruments market in 2023 owing to rising prevalence of eye disorders and surge in number of cataract surgeries performed within hospitals. Additionally, Specialty clinics is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements in ophthalmic surgery procedures, increasing adoption of advanced devices, and rising approvals by regulatory bodies. For instance, in June 2022, LENSAR, Inc., a medical technology company specializing in advanced femtosecond laser surgical solutions for cataract treatment, has obtained 510(k) clearance from the United States Food and Drug Administration (US FDA) for its next-generation ALLY Adaptive Cataract Treatment System. ALLY is among the initial FDA-approved platforms that enable cataract surgeons to perform femtosecond-laser-assisted cataract surgery entirely within a single, sterile setting.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of eye diseases in the region, rising technological advancements in ophthalmic surgery devices, surge in product launches, increasing government initiatives to support visually impaired populations, and growing collaborations within market players. For instance, in January 2022, Alcon, a company specializing in eye care, has successfully finalized its acquisition of Ivantis, a developer of the innovative Hydrus Microstent. This minimally invasive glaucoma surgery (MIGS) device is intended to reduce intraocular pressure in patients with open-angle glaucoma when performed alongside cataract surgery. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of cataracts & glaucoma, growing geriatric population, surge in technological advancements, rising government initiatives aimed at supporting the population affected by cataracts, and increasing launch of advanced products. For instance, in April 2022, Nova Eye Medical Limited, a medical technology company dedicated to cutting-edge ophthalmic treatment technologies and devices, has introduced its latest canaloplasty device, iTrack Advance, in specific markets across Europe and the Asia Pacific region.
Increasing technological advancements in ophthalmology surgery devices is predicted to boost the market growth during the forecast period. Ophthalmic surgical tools are essential for patients' complete comfort and convenience. The tools enable the eye expert to precisely determine each patient's condition and suggest the best course of treatment for recovery. The successful and effective use of this technology improves the overall eye screening procedure. For instance, in April 2022, Alcon has unveiled the Alcon Fidelis Virtual Reality (VR) Ophthalmic Surgical Simulator, a portable virtual reality device designed for trainee cataract surgeons. This simulator provides a realistic virtual operating room experience, complete with haptic feedback to replicate the visual and tactile aspects of cataract surgery.
By product, cataract surgery devices was the highest revenue-grossing segment in the global ophthalmic surgical instruments market in 2023 owing to the surge in number of cataract cases that require surgery, growing launch of new products, rising technological advancements in cataract surgery devices, increasing product launches in ophthalmology surgery devices. For instance, in August 2022, Sight Sciences, Inc., a company specializing in eye care technology with a mission to create innovative solutions that revolutionize healthcare and enhance patient well-being, has introduced SION, a surgical device that marks a significant advancement in the field of goniotomy innovation and practice. Additionally, Glaucoma surgery devices is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of glaucoma, increasing technological advancements, and growing launch of advanced products.
By end-user, hospitals was the highest revenue-grossing segment in the global ophthalmic surgical instruments market in 2023 owing to rising prevalence of eye disorders and surge in number of cataract surgeries performed within hospitals. Additionally, Specialty clinics is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements in ophthalmic surgery procedures, increasing adoption of advanced devices, and rising approvals by regulatory bodies. For instance, in June 2022, LENSAR, Inc., a medical technology company specializing in advanced femtosecond laser surgical solutions for cataract treatment, has obtained 510(k) clearance from the United States Food and Drug Administration (US FDA) for its next-generation ALLY Adaptive Cataract Treatment System. ALLY is among the initial FDA-approved platforms that enable cataract surgeons to perform femtosecond-laser-assisted cataract surgery entirely within a single, sterile setting.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of eye diseases in the region, rising technological advancements in ophthalmic surgery devices, surge in product launches, increasing government initiatives to support visually impaired populations, and growing collaborations within market players. For instance, in January 2022, Alcon, a company specializing in eye care, has successfully finalized its acquisition of Ivantis, a developer of the innovative Hydrus Microstent. This minimally invasive glaucoma surgery (MIGS) device is intended to reduce intraocular pressure in patients with open-angle glaucoma when performed alongside cataract surgery. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of cataracts & glaucoma, growing geriatric population, surge in technological advancements, rising government initiatives aimed at supporting the population affected by cataracts, and increasing launch of advanced products. For instance, in April 2022, Nova Eye Medical Limited, a medical technology company dedicated to cutting-edge ophthalmic treatment technologies and devices, has introduced its latest canaloplasty device, iTrack Advance, in specific markets across Europe and the Asia Pacific region.
Segmentation: Ophthalmic Surgical Instruments Market Report 2022 - 2033
Ophthalmic Surgical Instruments Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
Glaucoma Surgery Devices
- Microinvasive Glaucoma Surgery Devices
- Glaucoma Surgery Instruments & Kits
- Glaucoma Drainage Devices (GDDS)
- Glaucoma Stents and Implants
- Glaucoma Laser Systems
Cataract Surgery Devices
- Intraocular Lenses (IOLs)
- Ophthalmic Viscoelastic Devices (OVDs)
- Phacoemulsification Devices
- Cataract Surgery Lasers
- IOL Injectors
- Cataract Surgery Instruments and Kits
Refractive Surgery Devices
- Femtosecond Lasers
- Excimer Lasers
- Refractive Surgery Instruments & Kits
- Others
Vitreoretinal Surgery Devices
- Vitreoretinal Packs
- Vitreoretinal Machines
- Vitreoretinal Probes
- Vitreoretinal Surgery Instruments & Kits
- Photocoagulation Lasers
- Illumination Devices
- Accessories
- Ophthalmic Microscopes
- Others
Ophthalmic Surgical Instruments Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Specialty Clinics
- Hospitals
- Ambulatory Surgical Centers
Ophthalmic Surgical Instruments Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Ophthalmic Surgical Instruments Market: Product Estimates & Trend Analysis
8. Ophthalmic Surgical Instruments Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Ophthalmic Surgical Instruments Market
11. Europe Global Ophthalmic Surgical Instruments Market
12. Asia Pacific Global Ophthalmic Surgical Instruments Market
13. Latin America Global Ophthalmic Surgical Instruments Market
14. MEA Global Ophthalmic Surgical Instruments Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Carl Zeiss AG
- Appasamy Associates
- Topcon Corporation
- STAAR Surgical Company
- Millennium Surgical Corp
- Lumenis Ltd
- Katalyst Surgical
- Hoya Corporation
- ASICO LLC.
- Ziemer Ophthalmic Systems AG
- INKA Surgical Instruments.
- Ellex Medical Laser Ltd
- Glaukos
- Surgical Holdings
- Bausch Health (Bausch & Lomb Incorporated)
- Johnson & Johnson
- Haag-Streit Group
- Alcon Inc
- EssilorLuxottica (Essilor)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 11.9 Billion |
| Forecasted Market Value ( USD | $ 23.75 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 19 |
